Today, we revisit a small cap oncology concern called Immutep for the first time in two years. Read my investment analysis of IMMP stock.Read full newsRead More
Profire Energy has shown cyclical revenues and high operational leverage. See why I think PFIE stock seems expensive in terms of historical earnings.Read full newsRead More
Nextdoor trades near all-time lows despite a strong rally in small caps during January. See why investors should use this opportunity to buy KIND stock.Read full newsRead More
Alpha Metallurgical Resources is a coal company that reported impressive earnings. Check out our investment analysis of the AMR stock.Read full newsRead More
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.Read full newsRead More
Intel's business is going through a major cyclical post-pandemic adjustment period. Click here to see why I see very little up-side for INTC stock.Read full newsRead More
MINT is an actively-managed ETF, investing in short-term, investment-grade bonds. Read more to see what makes the fund a buy.Read full newsRead More
We have hit the debt limit and we have a problem. I offer my thoughts on how can we put off the problem.Read full newsRead More
KARS provides diverse exposure to the entire EV value chain without overweight exposure to Tesla. Find out more about KARS here.Read full newsRead More
Shares of Transocean have ripped higher to start 2023 and are up nearly 40% YTD. Click here to see our take on RIG stock.Read full newsRead More
In this article, I would like to highlight two SWAN stocks that are perfect for almost any investor profile. Check out our picks.Read full newsRead More
I think Datadog is too cheap, the chart looks like the bears are finally starting to lose momentum. See why I'm sticking with my buy rating on DDOG stock.Read full newsRead More
Equifax's softer performance and big recent rebound make me cautious. Click here to see why I feel no temptation to acquire EFX stock.Read full newsRead More
Investors are counting on inflation melting away by the summer. Click here to read the reasons why inflation may come back sooner than you think.Read full newsRead More
Viomi's results were affected significantly by China's zero COVID policy. Click here to see why I rate VIOT stock as a speculative buy.Read full newsRead More
Medical devices company Becton, Dickinson spun off Embecta last year. Click here to read my analysis of EMBC stock and why it is a hold.Read full newsRead More
DermTech's skin diagnostic test, dubbed DMT, has an uncanny ability to pick up the highly prevalent skin cancer, melanoma. Read why DMTK stock is a Buy.Read full newsRead More
I am optimistic about Vicor's future and differentiation strategy. Read more to see my PTs for VICR stock and why I believe the stock is undervalued.Read full newsRead More
Shares of Zuora have slipped nearly 60% over the past year. See why ZUO stock is one of the cheapest SaaS stocks on the market.Read full newsRead More
Weekly summary of dividend activity for dividend champions, contenders, and challengers. Read more to see the companies with upcoming ex-dividend dates.Read full newsRead More